News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Oct 10, 2022 Stanley Erck Opening Statement European Parliament – COVI Committee Hearing Delivered: October 10, 2022 Download Oct 10, 2022 COVID-19Seasonal influenza Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Europe 2022 Download Oct 10, 2022 Statement Novavax and SK bioscience File a Post Approval Change Application in South Korea for Nuvaxovid™ COVID-19 Vaccine as a Booster in Adults Aged 18 and Older Download Oct 10, 2022 Statement Switzerland’s Federal Office of Public Health Recommends Novavax Nuvaxovid™ COVID-19 Vaccine as a Booster in Adults Aged 18 and Older Download Sep 27, 2022 COVID-19 Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kingdom Download Sep 16, 2022 COVID-19 Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Aged 12 Through 17 Download Sep 16, 2022 Statement Novavax Requests Updated Emergency Use Listing from World Health Organization for Nuvaxovid™ COVID-19 Vaccine as a Booster in Adults Aged 18 and Older Download Sep 16, 2022 COVID-19 Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older Download Sep 13, 2022 COVID-19 Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine as a Primary Series for Adults Aged 18 and Older Download Sep 12, 2022 COVID-19 Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Use as a Booster for Adults Aged 18 and Older Download Show 5102550100 per page«123456789…45»